REFERENCES
- Richards AM. The natriuretic peptides and hyper-tension. J Intern Med 1994; 235: 543 — 60.
- Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990; 70: 665 — 99.
- Anggard E. Nitric oxide: mediator, murderer, and medicine [see comments]. Lancet 1994; 343: 1199 — 206.
- Hishikawa K, Nakaki T, Tsuda M, Esumi H, Ohshima H, Suzuki, H, et al. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 1992; J 33: 41 — 8.
- Blatter LA, Taha Z, Mesaros S, Shacklock PS, Wier WG, Malinski T. Simultaneous measurements of Ca2 + and nitric oxide in bradykinin-stimulated vascular endothelial cells. Circ Res 1995; 76: 922 — 4.
- Skidgel RA, Erdös EG. Biochemistry of angioten-sin I-converting enzyme. In: Robertson, Nicholls G, editors. The renin-angiotensin system, vol. 1. I. London: Gower Medical, 1993: 10.1–10.10.
- Hirata Y, Ishii M, Matsuoka H, Sugimoto T, Iizuka M, Uchida Y, et al. Plasma concentrations of alpha-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease. Am Heart J 1987; 113: 1463 — 9.
- Wencker M, Hauptlorenz S, Moll W, Puschendorf B. Influence of blood pressure, heart rate, age, and sex on concentrations of atrial natriuretic factor and cyclic GMP in 124 volunteers. Clin Chem 1989; 35: 1519 — 23.
- Fagard R, Staessen J, Thijs L, Amery A. Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. A meta analysis of comparative studies [published erratum appears in Am J Hypertens 1995 Nov; 8(11): 1146]. Am J Hypertens 1995; 8: 533 — 40.
- Nystrom F, Ekman B, Osterlund M, Lindstrom T, Ohman KP, Arnqvist HJ. Serum leptin concentra-tions in a normal population and in GH deficiency: negative correlation to testosterone in men and effects of GH treatment. Clin Endocrinol 1997; 47: 191 — 8.
- Nystr6m F, Malmström 0, Karlberg BE, Ohman KP. Twenty-four hour ambulatory blood pressure in the population. J Intern Med 1996; 240:279 —84.
- Nystrom FH, Ohman KP, Ekman BA, Osterlund MK, Karlberg BE, Arnqvist HJ. Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthro-pometric variables. Eur J Endocrinol 1997; 136: 165 — 72.
- Leppert J, Ringqvist A, Ahlner J, Myrdal U, Sorensen S, Ringqvist I. Cold exposure increases cyclic guanosine monophosphate in healthy women but not in women with Raynaud's phenomenon. J Int Med 1995; 237: 493 — 8.
- Olsson K, Karlberg BE, Eriksson L. Atrial natriuretic peptide in pregnant and lactating goats. Acta Endocrinol (Copenh) 1989; 120: 519 — 25.
- Buttery JE, Stuart S. Assessment and optimization of kinetic methods for angiotensin- converting enzyme in plasma. Clin Chem 1993; 39: 312 — 6.
- Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO 3rd. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormal-ity is not localized to a single signal transduction pathway. Circulation 1995; 91: 1732 — 8.
- Glasser SP, Selwyn AP, Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am Heart J 1996; 131: 379 — 84.
- Kohno M, Yasunari K, Takaori K, Takeda T. Increased plasma atrial natriuretic polypeptide in patients with severe essential hypertension and its decline with antihypertensive therapy with nifedi-pine [letter]. Arch Intern Med 1986; 146: 1226–7.